Legend Biotech LEGN
NASDAQ LEGN
$18.90 +0.27 (+1.45%)
At close: Oct 22, 2026 · 4:00 PM EDT

Legend Biotech (LEGN) Net Equity Issued and Repurchased (2020 - 2026)

Updated

Legend Biotech's Net Equity Issued and Repurchased was $200,000 in Q2 2026, down 33.3% from $300,000 a year earlier but up 100.0% from the prior quarter.

Analysis

Legend Biotech (LEGN) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Legend Biotech's Net Equity Issued and Repurchased was $1.9 million through Jun 30, 2026, down 75.3% year-over-year; for FY2025, it came in at $3.3 million, down 66.0% from FY2024.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -62.6% (FY2020 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $9.7 million in FY2024 (-17.8%), $11.8 million in FY2023 (+302.9%), $2.93 million in FY2022 (-36.9%) and $4.64 million in FY2021 (-99.0%).
  • Quarterly Net Equity Issued and Repurchased has moved between $100,000 (Q1 2026) and $8.14 million (Q2 2023) over five years.
  • Compared with a year earlier, Net Equity Issued and Repurchased has declined for seven straight quarters, with an average decline of 31.0% over the last eight quarters.
  • The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q2 2023 (growth of 667.5%); the worst was Q1 2026 (a decline of 92.9%).
  • Per Business Quant data, LEGN's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $100,000 (Q1 2026), $311,000 (Q4 2025) and $1.29 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -966.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -9.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 6.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -346.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Legend Biotech 3.48 Bn 983.57 Mn 251.50 Mn 212.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 212.60 Mn
Mar 31, 2026 100,000.00
Dec 31, 2025 311,000.00
Sep 30, 2025 1.29 Mn
Jun 30, 2025 300,000.00
Mar 31, 2025 1.40 Mn
Dec 31, 2024 603,000.00
Sep 30, 2024 5.41 Mn
Jun 30, 2024 2.12 Mn
Mar 31, 2024 1.59 Mn
Dec 31, 2023 621,000.00
Jun 30, 2023 8.14 Mn
Mar 31, 2023 370,000.00
Dec 31, 2022 624,000.00
Jun 30, 2022 1.06 Mn
Mar 31, 2022 459,000.00
Dec 31, 2021 543,000.00
Sep 30, 2021 1.59 Mn
Jun 30, 2021 2.13 Mn
Mar 31, 2021 378,000.00
API Access

Legend Biotech Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LEGN&period=max&api_key=YOUR_API_KEY